INmune Bio Announces Publication of Myeloid-Derived Suppressor Cells (MDSC) Report in the Cell’s Trends in Pharmacological Sciences Journal
07 déc. 2018 09h00 HE
|
INmune Bio, Inc.
Manuscript highlights the vital role of MDSC in the tumor microenvironment (TME) LA JOLLA, Calif.,, Dec. 07, 2018 (GLOBE NEWSWIRE) -- INmune Bio Inc., an immunotherapy company developing...
INmune Nominated for Buzz of Bio Award at 2019 CEO & Investor Conference
04 déc. 2018 08h30 HE
|
INmune Bio, Inc.
-Voting begins today: Click here to cast your vote- LA JOLLA, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- INmune Bio, Inc., an immunotherapy company focused on developing therapies that harness...
Greenpro Capital Corp. Announces Launch of ADAQ and Collaboration with PIKOM and SEATech Ventures
03 déc. 2018 08h30 HE
|
Greenpro Capital Corp.
Hong Kong, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Greenpro Capital Corp. ("Greenpro" or the "Company") (Nasdaq:GRNQ), a multinational conglomerate with a diversified capital portfolio, today announced...
Greenpro Capital Corp. Holds Annual “Worldwide Wealth Wisdom” Summit
28 nov. 2018 16h30 HE
|
Greenpro Capital Corp.
Hong Kong, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Greenpro Capital Corp. ("Greenpro" or the "Company") (Nasdaq:GRNQ), a multinational conglomerate with a diversified capital portfolio, today announced...